TRIM21 deficiency promotes cell proliferation and tumorigenesis via regulating p21 expression in ovarian cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Kostova I, Mandal R, Becker S, et al. The role of caspase-8 in the tumor microenvironment of ovarian cancer. Cancer Metastasis Rev. 2021;40(1):303–318.
   PubMed Web of Science ®Google Scholar
• Ghoneum A, Afify H, Salih Z, et al. Role of tumor microenvironment in the pathobiology of ovarian cancer: insights and therapeutic opportunities. Cancer Med. 2018;7(10):5047–5056.
   PubMed Web of Science ®Google Scholar
• Brasseur K, Gévry N, Asselin E. Chemoresistance and targeted therapies in ovarian and endometrial cancers. Oncotarget. 2017;8(3):4008–4042.
   PubMedGoogle Scholar
• Wada K, Kamitani T. Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem Biophys Res Commun. 2006;339(1):415–421.
   PubMed Web of Science ®Google Scholar
• Kiss L, Zeng J, Dickson CF, et al. A tri-ionic anchor mechanism drives Ube2N-specific recruitment and K63-chain ubiquitination in TRIM ligases. Nat Commun. 2019;10(1):4502.
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Chan EK, Sullivan KF, et al. A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med. 1988;167(5):1560–1571.
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Fox RI, Tan EM. Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren’s syndrome. Arthritis Rheum. 1990;33(3):349–355.
   PubMed Web of Science ®Google Scholar
• Rhodes DA, Isenberg DA. TRIM21 and the Function of Antibodies inside Cells. Trends Immunol. 2017;38(12):916–926.
   PubMed Web of Science ®Google Scholar
• Ding Q, He D, He K, et al. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers. Tumour Biol. 2015;36(11):8761–8772.
   PubMedGoogle Scholar
• Brauner S, Zhou W, Backlin C, et al. Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease. J Intern Med. 2015;278(3):323–332.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wang Y, Yun D, et al. TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma. Am J Cancer Res. 2020;10(1):114–130.
   PubMed Web of Science ®Google Scholar
• Chen X, Li Z, Yong H, et al. Trim21-mediated HIF-1α degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis. Cancer Lett. 2021;508:115–126.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang D, Lu J, et al. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis. Cell Death Differ. 2020;27(12):3226–3242.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang D, Chen X, et al. PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis. Cell Death Dis. 2021;12(11):1080.
   PubMed Web of Science ®Google Scholar
• Hou P, Li L, Chen F, et al. PTBP3-mediated regulation of ZEB1 mRNA stability promotes epithelial-mesenchymal transition in breast cancer. Cancer Res. 2018;78(2):387–398.
   PubMed Web of Science ®Google Scholar
• Li Z, Hou P, Fan D, et al. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Cell Death Differ. 2017;24(1):59–71.
   PubMed Web of Science ®Google Scholar
• Li Y, Fei H, Lin Q, et al. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers. Oncogene. 2021;40(32):5131–5141.
   PubMed Web of Science ®Google Scholar
• Jauharoh SN, Saegusa J, Sugimoto T, et al. SS-A/Ro52 promotes apoptosis by regulating Bcl-2 production. Biochem Biophys Res Commun. 2012;417(1):582–587.
   PubMed Web of Science ®Google Scholar
• Gao X, Xu F, Zhang HT, et al. PKCα-GSK3β-NF-κB signaling pathway and the possible involvement of TRIM21 in TRAIL-induced apoptosis. Biochem Cell Biol. 2016;94(3):256–264.
   PubMed Web of Science ®Google Scholar
• Jin J, Meng X, Huo Y, et al. Induced TRIM21 ISGylation by IFN-β enhances p62 ubiquitination to prevent its autophagosome targeting. Cell Death Dis. 2021;12(7):697.
   PubMed Web of Science ®Google Scholar
• Collin G, Huna A, Warnier M, et al. Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence. Cell Death Dis. 2018;9(3):259.
   PubMed Web of Science ®Google Scholar
• Zhu D, Shi C, Jiang Y, et al. Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21. Bioengineered. 2021;12(1):1505–1516.
   PubMed Web of Science ®Google Scholar
• Reddy BA, van der Knaap JA, Bot AG, et al. Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization. Mol Cell. 2014;53(3):458–470.
   PubMed Web of Science ®Google Scholar
• Guha A, Ahuja D, Das Mandal S, et al. Integrated Regulation of HuR by Translation Repression and Protein Degradation Determines Pulsatile Expression of p53 Under DNA Damage. iScience. 2019;15:342–359.
   PubMed Web of Science ®Google Scholar
• Loret N, Denys H, Tummers P, et al. The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance. Cancers (Basel). 2019;11(6):838.
   PubMed Web of Science ®Google Scholar
• Bou-Tayeh B, Miller ML. Ovarian tumors orchestrate distinct cellular compositions. Immunity. 2021;54(6):1107–1109.
   PubMed Web of Science ®Google Scholar
• Desbois M, Udyavar AR, Ryner L, et al. Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer. Nat Commun. 2020;11(1):5583.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang Y, Shen J, et al. The ubiquitin E3 ligase TRIM21 promotes hepatocarcinogenesis by suppressing the p62-keap1-Nrf2 antioxidant pathway. Cell Mol Gastroenterol Hepatol. 2021;11(5):1369–1385.
   PubMed Web of Science ®Google Scholar
• Christofk HR, Vander Heiden MG, Harris MH, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452(7184):230–233.
   PubMed Web of Science ®Google Scholar